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ABSTRACT 
ASSESSING THE USE OF THE STEEP RAMP TEST IN CHRONIC OBSTRUCTIVE 
PULMONARY DISEASE 
The purpose of this study was to compare power output and ventilatory measurements 
between the steep ramp test (SR) and both the 30-second Wingate anaerobic (WAT) and 
standard cardiopulmonary exercise tests (CPET) in chronic obstructive pulmonary disease 
(COPD).  11 patients (7 males and 4 females) underwent spirometry, a CPET, WAT and SR test.  
Repeated measures ANOVA was used to compare the differences between the peak work rate of 
the CPET (CPETpeak), SR (SRpeak), and the average power of the WAT (Wavg).  The Wavg was 
higher than the SRpeak, which was higher than the CPET (231.2 ± 113.4, 156.8 ± 67.9, 65.9 ± 
35.9, p<0.05 respectively).  There were no differences found between the tests at end-exercise 
for inspiratory reserve volume (IRV), ventilation (VE), and end-expiratory lung volume (EELV).  
Tidal volume (VT) was also compared between the tests as a percentage of the inspiratory 
capacity (IC) remaining at end-exercise and no differences were found.  The similarity between 
the ventilatory measures indicates a similar level of constraint, despite the large difference in 
work rates achieved, in all 3 tests.  This shows that a standard CPET underestimates leg power in 
COPD patients, and the WAT and SR may be better indicators of leg muscle power and 
anaerobic type exercise. 
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CHAPTER 1 
BACKGROUND 
1.1  INTRODUCTION 
Chronic Obstructive Pulmonary Disease (COPD) is one of Canada’s fastest growing chronic 
diseases, leading to increased mortality (Lacasse, Brooks, & Goldstein, 1999), as well as 
numerous complicating co-morbidities in various clinical situations (Bourbeau, Nault, & 
Borycki, 2002; O'Donnell et al., 2007).  COPD is the current preferred term for abnormalities of 
the lung including chronic bronchitis and emphysema (Bourbeau et al., 2002).  It is usually 
caused by smoking and is characterized by partially reversible airway obstruction, impaired gas 
exchange, lung hyperinflation, chronic cough and systemic manifestations (O'Donnell et al., 
2007).  Initially, the respiratory deficiencies are most prominent in COPD (O'Donnell et al., 
2007); however, derangements of the skeletal muscle and cardiovascular system also typically 
occur in advanced disease (Butcher & Jones, 2006). 
Individuals with COPD are often prescribed aerobic exercise to enhance function and reduce 
shortness of breath during activities of daily living.  Current recommendations have progressed 
beyond general guidelines to suggest that exercise at higher intensities is more beneficial for this 
population (Casaburi et al., 1997; Coppoolse et al., 1999).  Unfortunately, ventilatory limitations 
may not allow high intensity continuous exercise to be tolerated for long periods of time, which 
leads to frequent rest breaks (Puhan et al., 2006) and potentially reduced adherence to prescribed 
exercise.  A predominance of type II muscle fibers caused by muscle myopathy (O'Donnell et al., 
2007) in these patients also may not be conducive to long term aerobic activity.  In addition, a 
pattern of very high energy demand followed by rest periods is often found during activities of 
daily living for these patients resulting in an increased use of anaerobic energy to accomplish 
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these activities (Coppoolse et al., 1999; Smodlaka & Adamovich, 1974).  If enhanced daily 
function is the goal, it might be desirable if a similar pattern of training was reflected in the 
design and content of their exercise program.   
Interval training is similar to the pattern of activities of daily living for COPD patients by 
including periods of high intensity work interspersed with periods of rest.  Interval training has 
not traditionally been used in this population and there is a lack of consensus in regards to 
prescription guidelines.  Interval exercise intensity may be prescribed for healthy individuals 
based on tests of anaerobic power and capacity, such as a Wingate Anaerobic Test (WAT), but 
these types of tests have not been widely used for individuals with COPD.  The steep ramp (SR) 
test has been used repeatedly in the literature to prescribe interval training intensities for 
individuals with chronic heart failure (Meyer et al., 1996; Meyer, Schwaibold et al., 1996; Meyer 
et al., 1997), so it may also be effective for use in COPD patients because many of the peripheral 
skeletal muscle derangements in chronic heart failure and COPD are similar. 
1.2  REVIEW OF LITERATURE 
The review of the literature outlines the current recommendations for exercise prescription, 
the physiological limitations in COPD which make it difficult for these patients to exercise and 
perform activities of daily living, and some emerging research trends that suggest that high 
intensity interval training may be beneficial in COPD.   
1.2.1  Current Recommendations 
Aerobic exercise training has long been known to improve the health status and quality of 
life of individuals with COPD (Durstine & Moore, 2003).  Significant and clinically meaningful 
improvements in exercise tolerance (O'Donnell et al., 2007; Ries et al., 2007), decreased dyspnea 
(Balady et al., 2000; Ries et al., 2007) and a reduction in dynamic hyperinflation (Porszasz et al., 
2005) have been observed through exercise training.  Exercise prescription varies slightly 
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depending on the goals and abilities of the individual.  Table 1.1 illustrates the suggested 
prescription for aerobic and strength training for individuals with COPD based on American 
College of Sports Medicine (ACSM) guidelines (Durstine & Moore, 2003);  however, a further 
understanding of the guidelines is necessary in order to adjust and optimize prescription for each 
individual. 
The ACSM recommendations for aerobic exercise training for individuals with COPD are 
limited to submaximal training factors that focus on duration rather than intensity.  As when 
prescribing exercise in the normal population, a focus on large muscle activities is desirable for 
an aerobic response (Balady et al., 2000).  Walking and cycling are straightforward exercises for 
COPD patients, and they may be easily monitored under appropriate supervision in a clinical 
setting.  The frequency of exercise sessions should be 3-7 days per week depending whether the 
desired results are for maintenance or for a training effect.  A goal of 30 minutes of sustained 
exercise per training session is desirable, but most individuals will only initially be able to 
tolerate a few minutes at a time due to deconditioning and dyspnea (Durstine & Moore, 2003).  
Therefore, rest breaks may be taken initially, to attain relief of symptoms, in order to complete a 
continuous exercise training session (Durstine & Moore, 2003).   
The intensity of exercise is prescribed differently than in normal individuals due to the 
ventilatory restrictions experienced in COPD (Horowitz, Littenberg, & Mahler, 1996).  It may be 
difficult to accurately prescribe intensity with traditional measures such as heart rate reserve or a 
percentage of maximal oxygen consumption because many individuals reach a ventilatory 
mechanical limit, due in part to dynamic hyperinflation, increased dead space ventilation,  
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Table 1.1.  Aerobic exercise guidelines for COPD 
 
Mode Frequency Intensity Duration 
 
Aerobic 
walking or cycling 
 
 
3-7 days/wk 
 
 
RPE 11-13/20 
Dyspnea scale 5/10 
 
 
 
Goal: 30 mins (shorter 
sessions may be 
necessary initially) 
Emphasize increasing 
duration>intensity 
RPE = Rate of perceived exertion.  Adapted from ACSM’s exercise management for persons 
with chronic diseases and disabilities, 2nd ed (Durstine & Moore, 2003).
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increased work of breathing, and impaired gas exchange before they are able to reach a true 
cardiovascular limit (Butcher & Jones, 2006; Horowitz et al., 1996).   
It is acceptable to monitor subjective intensity and symptoms using ratings of perceived 
exertion (RPE) and/or a dyspnea rating scale.  It has been demonstrated that individuals with 
COPD are able to reproduce a desired intensity using a dyspnea target of 5/10 (“severe”) during 
10 minutes of submaximal exercise (Horowitz et al., 1996).  By increasing exercise endurance 
through aerobic training, individuals experience increased quality of life and positive 
physiological responses (O'Donnell et al., 2007). 
More recent research has suggested that higher intensity continuous training is more 
beneficial for COPD patients (Casaburi et al., 1997; Coppoolse et al., 1999)  and that 60% of 
peak work rate (PWR) is sufficient for producing a training response (Coppoolse et al., 1999).  In 
recognizing the need to exercise above anaerobic threshold to induce a training response, the 
American Thoracic Society and European Respiratory Society have updated their guidelines to 
suggest continuous aerobic exercise at >60% PWR for >30 minutes, >3 times per week may be 
beneficial (Nici et al., 2006).   
Resistance training is an important component of pulmonary rehabilitation in order to 
increase muscle strength and mass, which may make activities of daily living easier.  Table 1.2 
displays the ACSM guidelines for strength training for this population (Durstine & Moore, 
2003).  The ACSM focuses on high repetitions and low resistance, which follows their 
recommendations to concentrate on endurance rather than intensity for this population.  Similar 
to the recent research outlined above regarding higher intensity aerobic training, it may be 
beneficial in some cases to increase resistance and reduce repetitions in order to maintain a 
training effect while decreasing dyspnea.  It has been shown in elderly male COPD patients that  
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Table 1.2.  Strength training guidelines for COPD 
 
Mode Frequency Intensity 
 
Strength 
Free weights or 
machines 
 
 
2-3 days/wk 
 
 
Low resistance, high reps 
Goal: increase number of reps 
 
Adapted from ACSM’s exercise management for persons with chronic diseases and disabilities, 
2nd ed (Durstine & Moore, 2003).
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heavy resistance training twice a week produced significant improvements in strength and was 
tolerated well by the participants (Kongsgaard, Backer, Jorgensen, Kjaer, & Beyer, 2004).  The 
American Thoracic Society and European Respiratory Society (ATS/ERS) recommendations 
seem to find a balance between conservative prescription and this recent research to suggest that 
strength training include 2-4 sets of 6-12 repetitions at an intensity of 50-85% of a one repetition 
maximum (Nici et al., 2006).  However, it is prudent to start any exercise program at a lower 
intensity, as with normal subjects, in order to ensure proper technique, reduce the likelihood of 
muscle soreness, and promote adherence to exercise. 
1.2.2  Physiological Limitations 
The physiological limitations to exercise experienced by individuals with COPD, and the 
reasons behind them, may not be immediately obvious to those prescribing or monitoring 
exercise in this population.  There are factors of the disease itself that are not fully understood 
but seem to have an impact on exercise and activities of daily living.  Some physiological 
limitations to exercise are outlined below.  COPD patients may or may not exhibit all of these 
limitations to exercise depending on the severity and course of their disease. 
1.2.2.1  Ventilation 
There are multiple factors that contribute to exercise limitations in COPD patients, but 
limited ventilation is one of the primary issues (O'Donnell, Revill, & Webb, 2001; O'Donnell & 
Webb, 2008).  Lung function becomes compromised when pathological processes begin to take 
place in the lung tissue.  Lung tissue destruction caused by inflammatory processes results in 
decreased tissue elastin and small airway collapse (O'Donnell et al., 2007).  The result of these 
processes is airway closure and distal air trapping that occurs primarily during expiration 
(Bourbeau et al., 2002).  The decreased elastic recoil of the lungs results in a reduced driving 
 17 
force during expiration, which is unable to maintain patency of the small airways and limits 
expiratory flow rates (Bourbeau et al., 2002; O'Donnell et al., 2007).  This expiratory flow 
limitation is the hallmark of the disease (O'Donnell et al., 2007).  Gas exchange abnormalities 
are also common, and many individuals experience hypoxemia and respiratory acidosis from the 
retained carbon dioxide (CO2) (West, 2003).   
Airway obstruction can cause air trapping which becomes more prominent during exercise, 
or some activities of daily living, where an increase in tidal volume (VT) and respiratory rate 
(RR) is necessary to cope with increasing physiological demands (Butcher & Jones, 2006; 
Vogiatzis et al., 2004).  However, due to the expiratory flow limitation, they are unable to 
completely exhale before needing to take another breath.  The individual continues to inhale 
more than they exhale and this causes dynamic hyperinflation (O'Donnell et al., 2001; O'Donnell 
& Webb, 2008)  and a rapid shallow breathing pattern.  A number of consequences take place as 
more air trapping occurs: end-expiratory lung volume (EELV) increases, inspiratory reserve 
volume (IRV) is markedly reduced, and VT approaches the upper limits of total lung capacity 
(TLC) (See Figure 1.1) (Butcher & Jones, 2006; Porszasz et al., 2005; Vogiatzis et al., 2004; 
Vogiatzis et al., 2005).  Added to this is the physiological strain of the respiratory muscles 
working in a shortened position due to the hyperinflation of the lungs (Porszasz et al., 2005).  
The increased work of breathing adds to the negative consequences experienced by the patient 
due to their rapid, shallow breathing pattern.  This cycle causes the individual with COPD to 
become short of breath, activity limited, and exhausted very quickly with minimal activity.   
Many individuals with COPD do not reach a maximal heart rate or maximal rate of oxygen 
consumption (VO2max) during a maximal incremental exercise test due to the early onset 
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Figure 1.1.  Ventilation during exercise in an individual without COPD (top) and with COPD 
(bottom).  Normal increases in respiratory rate and tidal volume also result in increased 
inspiratory capacity in the individual without COPD.  In COPD, dynamic hyperinflation is 
associated with exercise lung volume and reduced inspiratory capacity.
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of dynamic hyperinflation (Butcher & Jones, 2006; Vogiatzis et al., 2004; Vogiatzis et al., 2005).  
Therefore, the common practice of prescribing exercise as a percentage of VO2max, PWR or peak 
heart rate should not be used because the work rate prescribed will likely underestimate the 
patient’s true capabilities (Butcher & Jones, 2006; Meyer et al., 1996).  
1.2.2.2  Muscle Dysfunction 
For many patients, especially in milder cases of COPD, leg fatigue is the limiting factor to 
exercise (A. Aliverti & Macklem, 2001; Butcher, 2008).  Although the patient may complain of 
muscle fatigue, it is likely that lack of oxygen delivery to the peripheral muscles is a contributor 
in their exercise limitation (A. Aliverti & Macklem, 2008).  Lung obstruction and dynamic 
hyperinflation causes the respiratory muscles to be demanding of oxygen at the expense of other 
peripheral muscles.  The respiratory muscles may use up to 55% of the available oxygen supply, 
robbing the locomotor muscles of much needed oxygen for continued function during exercise 
(A. Aliverti & Macklem, 2008).  Peripheral muscle dysfunction may also be caused by chronic 
disuse of muscles, decreased fat free mass and altered fiber type (Jagoe & Engelen, 2003).  
Although these physiological findings related to muscle dysfunction are not fully understood, 
there are COPD related factors that may play a role in their origin (Jagoe & Engelen, 2003). 
COPD patients often have a reduced muscle mass, or fat free mass, as a result of muscle 
wasting (O'Donnell et al., 2007).  This wasting may be caused by disuse, which not only causes 
atrophy of the muscle itself but also causes a shift in the ratio of fiber type from fewer oxidative 
type I fibers to more glycolytic fast twitch type II fibers (Jagoe & Engelen, 2003).  Gosker et al 
(Gosker, Hesselink, Duimel, Ward, & Schols,A M W J., 2007) found that the decreased 
oxidative capacity of the vastus lateralis in individuals with COPD is due to fewer mitochondria, 
which may be a result of fewer type I fibers (Gosker et al., 2007).  They also found that the 
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tibialis anterior muscle retained the proper mitochondrial ratio compared to normal individuals. 
It was postulated that since the tibialis muscle was required for almost constant postural 
activities, it was necessary to have more type I fibers (Gosker et al., 2007).  It is known that rest, 
disuse, or a reduction in activity, promotes a shift toward type II fibers (Harridge, 2007) and it 
may be the subjects in that study did not use their quadriceps muscles as extensively as the 
tibialis muscle on a day to day basis.  Exercise training helps to reduce the undesirable fiber type 
ratio in the vastus lateralis, or other peripheral muscles, toward a more favorable ratio of 
increased oxidative type I fibers used for prolonged activities (Harridge, 2007).  
Poor nutrition is a factor which may contribute to decreased muscle mass through reduced 
protein synthesis.  Decreased caloric intake or increased energy expenditure are believed to be 
partially to blame for muscle wasting (Jagoe & Engelen, 2003) but increasing caloric intake 
usually results in fat mass being gained in these patients (Jagoe & Engelen, 2003).  In addition, it 
may be important to examine the composition of the diet to ensure adequate protein is being 
consumed for protein synthesis to occur (Jagoe & Engelen, 2003).  The decreased cross-sectional 
area of type I and II fibers as well as the overall reduction in cross-sectional area of the muscle 
found in these patients is likely the result of a general protein deficit at the cellular level 
(Debigare & Maltais, 2008).  Even with sufficient protein available, the hypoxia observed in 
patients with COPD inhibits protein synthesis and may cause further proteolysis to occur through 
calcium-dependent proteolytic enzymes (Jagoe & Engelen, 2003).  Respiratory acidosis, which 
occurs with exacerbations or is present in more severe COPD, may also amplify proteolysis 
(Jagoe & Engelen, 2003). 
Although severe muscle wasting does not seem to be associated with occasional low-dose 
steroid use in COPD patients, muscle function may be impaired with acute high-dose or 
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cumulative steroid use (Jagoe & Engelen, 2003; Dekhuijzen & Decramer, 1992).  Cumulative 
moderate-dose systemic cortico-steroid use is known to cause limb muscle weakness followed by 
respiratory muscle involvement (Dekhuijzen & Decramer, 1992).  The effects of beta-2-agonists, 
a staple of therapy for COPD, on protein synthesis, muscle dysfunction, and ultimately exercise 
outcomes are not well understood (Jagoe & Engelen, 2003). 
Swallow et al (2007) found that quadriceps strength was a better indicator of mortality than 
ventilatory status in COPD patients.  To the best of my knowledge, it is unknown whether 
quadriceps strength is a causative factor of mortality or whether it is a marker of disease severity 
which also leads to mortality.  In the absence of such data, it is important to consider that it may 
be a causative factor that can be influenced by exercise training which would lead to a decreased 
risk of early mortality.  It may therefore be a disservice to COPD patients to solely counsel them 
to exercise aerobically without emphasizing the importance of muscle strength as well.  
Although COPD is classified as a lung disease, peripheral muscle dysfunction is present, and 
must be recognized as a multifactorial contributor to the disability patients experience.  The 
Canadian Thoracic Society recognizes the multiple issues affecting COPD patients and has 
reflected that in the classification guidelines (O'Donnell et al., 2008).  The guidelines recognize a 
connection between symptoms, disability and lung function impairment and are presented in 
Figures 1.2 and 1.3.  It is apparent that patients who are classified as “mild” according to their 
lung function impairment may find that they are classified as “moderate” according to their 
symptoms. 
As outlined above, a true physiologic maximum is often not achieved during incremental 
exercise testing causing an underestimation in the work rate that the individual can perform 
(Butcher & Jones, 2006).  A percentage of the underestimated PWR results in an intensity that  
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Figure 1.2.  Canadian respiratory guidelines linking dyspnea, stages of disease and disability. 
Canadian Thoracic Society 2008 Powerpoint slide update kit (Canadian thoracic society - 
guidelines & standards.) 
 
 
 
Figure 1.3.  Canadian respiratory guidelines classification of disease severity based on 
impairment of lung function. 
Canadian Thoracic Society 2008 Powerpoint slide update kit (Canadian thoracic society - 
guidelines & standards.) 
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contributes to dynamic hyperinflation but does not challenge the peripheral muscles and thus, 
minimizes potential strength gains and perhaps adds to the cycle of disuse and atrophy.  The 
under usage of peripheral muscles may lead to a high glycolytic to oxidative fiber type and 
enzyme ratio which further undermines the individual’s ability to perform endurance activity.   
Even if strength training is used to address the specific muscle weakness and myopathy that is 
present, a proper amount of protein and calories must be consumed in the diet to overcome the 
muscle wasting that occurs with cumulative steroid use (Jagoe & Engelen, 2003).  
It is obvious that the myopathy and cycle of disuse is a result of a myriad of factors acting 
positively or negatively on muscle physiology. The goal of exercise is to assist in achieving a 
positive balance of muscle protein synthesis and overall exercise capacity in order to help the 
individual become less symptomatic and more proficient with activities of daily living. 
1.2.3  Activities of Daily Living and COPD 
COPD patients are often diagnosed after they have noticed increasing shortness of breath 
with activities that were previously done with ease. These individuals appear to be able to 
perform activities of daily living that only require a low energy cost such as cooking, slow 
walking or light housework; however, other activities such as climbing stairs or walking briskly 
are often too difficult (Butcher & Jones, 2006).  Velloso et al (2003)  studied the physiological 
cost of COPD patients and controls performing 4 upper limb activities.  The groups were not 
compared except to comment regarding reliability of the testing.  The researchers found that the 
COPD patients did the activities at a significantly higher volume of consumed oxygen (VO2) 
(50.2% mean of VO2max) and ventilation (VE) (mean 55.7% of max voluntary ventilation) in 
relation to resting measurements, which the researchers thought likely explains the exhaustion 
COPD patients experience during activities of daily living (Velloso et al., 2003).  The energy 
cost was higher in the COPD patients and they would likely be unable to sustain those activities 
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for a long period of time without frequent rest breaks (Yquel et al., 2006).  There seems to be 
some activities of daily living that require a lower level of energy and others that require a higher 
level of functioning (Yquel et al., 2006).  Perrault (2006) found that the efficiency of the skeletal 
muscles to perform movement varies with the activity that is being performed.  Furthermore, 
individuals with COPD tend to have a greater energy demand and waste energy physiologically 
through a higher cost for ventilation and a reduced efficiency of muscle due to increased type II 
to type I fiber ratio (Perrault, 2006).   
At the onset of submaximal exercise, the phosphocreatine (PCr) and lactate anaerobic 
systems provide the energy necessary for the working muscles until the aerobic system is 
functioning well enough to replenish the adenosine triphosphate (ATP) for continued work 
(American College of Sports Medicine, 2006).  The oxygen debt must be overcome by aerobic 
metabolism in order to reach a steady state.  VO2 kinetics describes how quickly one is able to 
shift to aerobic metabolism and reduce the amount of initial muscle fatigue that occurs with the 
onset of exercise.  COPD patients have slower VO2 kinetics compared to age-matched controls 
(Casaburi et al., 1997) and this may be a reflection of the decreased number of type I fibers seen 
in the muscles.  With fewer type I fibers, there are fewer mitochondria available to contribute to 
aerobic metabolism and these patients have a prolonged anaerobic contribution to metabolism for 
a longer period of time than normal individuals.  Therefore, activities of daily living that may be 
low in intensity may still be largely anaerobic in individuals with COPD.   
Many of the changes in muscle physiology are also seen in chronic heart failure patients 
(Meyer et al., 1996) who also tend to have similar difficulties with activities of daily living that 
require both endurance and short bursts of energy (Meyer et al., 1996).  Individuals with COPD 
or chronic heart failure, depending on the severity of their disease, may be able to sustain low 
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energy activities for a longer period of time but find difficulty sustaining moderate or high 
energy activities without resting for short periods during the activity (Smodlaka & Adamovich, 
1974).  For example, those individuals will report that they may be able to walk slowly on the 
level for a long period of time, but are only able to climb stairs by taking rest breaks.  For 
patients with more severe disease, most of their daily activities must be completed by using rest 
breaks (Smodlaka & Adamovich, 1974).  For these individuals, their activity pattern closely 
resembles an anaerobic pattern of performing an activity for 1-2 minutes and then resting 
(Coppoolse et al., 1999).  They continually reinforce a short term, high energy expenditure 
pattern interrupted by periods of rest (Butcher & Jones, 2006; Coppoolse et al., 1999).  
Therefore, as training should be specific to the desired outcome, it appears important to train the 
anaerobic system using high work rate intervals to help these patients become more efficient 
with tasks of everyday living. 
1.2.4  Anaerobic Training 
Continuous exercise has been shown to increase PWR (Arnardóttir, Boman, Larsson, 
Hedenström, & Emtner, 2007; Vogiatzis et al., 2002), endurance time (Punzal, Ries, Kaplan, & 
Prewitt, 1991), VO2max (Arnardóttir et al., 2007; Coppoolse et al., 1999; Punzal et al., 1991), 
lactate threshold (Vogiatzis et al., 2002), capillary to muscle fiber ratio (Vogiatzis et al., 2005), 
and cross sectional area of muscle fibers (Vogiatzis et al., 2005) while decreasing symptoms 
(Punzal et al., 1991; Vogiatzis et al., 2002).  Unfortunately, ventilatory limitations often limit the 
intensity or amount of muscle activity that is sufficient to induce an increase in muscle mass or a 
shift to slow twitch fibers (Jagoe & Engelen, 2003).  
High intensity continuous training has been shown to be beneficial by Casaburi et al (1991) 
in their study comparing continuous exercise at intensities of 50% and 80% PWR in COPD 
patients with moderate disease.  Higher intensity may be associated with greater benefit of 
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training (Casaburi et al., 1991) but it is difficult to encourage patients to exercise at a high 
workload when they experience symptoms of dyspnea.  Maltais et al (Maltais et al., 1997) found 
that individuals with severe disease could not maintain continuous exercise at 80% PWR.  With 
these high levels of intensity, it becomes necessary for some patients to take unscheduled rest 
breaks during the session due to dyspnea (Puhan et al., 2006).  Interval training may be used to 
enhance fitness while allowing relief of symptoms during scheduled periods of rest or decreased 
intensity (Nici et al., 2006).   
The recommendation by the ATS/ERS that interval training is beneficial for COPD patients 
is based on the results from 2 trials (Coppoolse et al., 1999; Vogiatzis et al., 2002).  Coppoolse et 
al (1999) showed that interval training had a direct effect on increased PWR and a subjective 
decrease in leg pain.  They also found a more pronounced increase in aerobic power in the 
continuous training group as shown by a higher VO2max and a more significant decrease in lactic 
acid production during a submaximal exercise test (Coppoolse et al., 1999).  Although the 
sample size was small, it appeared that continuous training invoked a stronger aerobic response 
while the interval training increased anaerobic capacity as evidenced by improved exercise 
tolerance to lactic acid at higher work rates (Coppoolse et al., 1999).  Vogiatzis et al (2002) 
found similar responses but also found a decrease in dyspnea as well as leg fatigue in the interval 
training group.  This important finding suggests that patients can improve their fitness with the 
same total work load using high work rate intervals with less dyspnea than continuous exercise 
(Vogiatzis et al., 2002).  The differences in these studies may be related to study design.  The 
Coppoolse et al study prescribed interval training interspersed with continuous training to avoid 
possible injury to their interval training group (Coppoolse et al., 1999).  This reduced the total 
amount of high intensity intervals they performed over the training period compared to the 
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Vogiatzis et al study.  Also, Coppoolse et al used 1 min high intensity interspersed with 2 min of 
low intensity work, rather than the 30 second work to 30 second rest ratio in the Vogiatzis et al 
study.  This may have underestimated the differences in physiological response between 
continuous and interval training.  The longer intervals combined with the continuous nature of 
the interval training protocol in Coppoolse’s study may have contributed to as much dyspnea as 
continuous training in this population.(Vogiatzis et al., 2005) 
In another study by Vogiatzis et al (2004), COPD patients were evaluated with an initial 
graded incremental exercise test, followed by a constant load exercise test at 80% PWR, and then 
interval exercise including 100% PWR for 30 seconds and unloaded pedaling for 30 seconds.  
IRV was significantly higher after the interval exercise than for the other 2 tests indicating a 
decreased amount of dynamic hyperinflation.  The patients were able to exercise longer and for a 
higher total workload during the interval exercise than during the continuous exercise but with 
less lactate build-up, less hyperinflation and less pH acidity (Vogiatzis et al., 2004). 
Vogiatzis et al (2005) also studied skeletal muscle changes between interval exercise and 
constant load exercise groups in a 10 week study.  They found significant increases in capillary 
to fiber ratio, increases in cross sectional area of type I and IIa fibers and increased PWR in both 
groups.  There was no significant difference in these increases between the groups, but the 
ratings of perceived exertion and dyspnea were lower in the interval exercise group.  The interval 
exercise group was able to achieve the same physiological changes in the muscle with less 
discomfort (Vogiatzis et al., 2005). 
In the 3 studies by Vogiatzis et al (Vogiatzis et al., 2002; Vogiatzis et al., 2004; Vogiatzis et 
al., 2005) outlined above, the physiological and most ventilatory responses tend to be similar 
between the interval and continuous training groups.  Interval training has been shown to be 
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superior in these studies due to the fact that the patients can sustain interval exercise for longer 
periods of time with stable metabolic and ventilatory responses (Vogiatzis et al., 2004) and incur 
beneficial muscle adaptation (Vogiatzis et al., 2005) but with similar or fewer symptoms such as 
leg fatigue and dyspnea (Vogiatzis et al., 2002; Vogiatzis et al., 2004; Vogiatzis et al., 2005).  
Supporting these findings is a strong non-inferiority study in which Puhan et al (2006)  examined 
98 patients with severe COPD and proved that interval training was not inferior to high intensity 
continuous training, plus the patients experienced fewer symptoms.  Some other studies found 
significant increases in ventilatory responses in their interval training groups and no difference in 
symptoms between continuous and interval training groups (Arnardóttir et al., 2007; Gimenez, 
2000) but this may be due to the differences in methodology.  Vogiatzis et al use 30 second 
intervals in the 3 studies cited above (Vogiatzis et al., 2002; Vogiatzis et al., 2004; Vogiatzis et 
al., 2005) and Puhan et al (2006) used a work-rest ratio of 20s:40s, as opposed to 1-3 minutes 
high intensity and 3-4 minutes low intensity as found in some other studies (Arnardóttir et al., 
2007; Gimenez, 2000).  The increased length of high intensity intervals may appear to increase 
the aerobic response like that seen in high intensity continuous exercise, but it also increases the 
dyspnea experienced by the patient.  While high intensity training appears to be more beneficial 
for individuals with COPD, anxiety and dyspnea may be overwhelming to the beginner.  It is 
important to note that training at lower intensities may be necessary to ensure compliance (Nici 
et al., 2006).  It may be more important to have the patient subscribe fully to the rehabilitation 
program than to be rigid about training intensities or protocols at the expense of participation. 
1.2.5  Anaerobic Testing 
If interval exercise is used to stress anaerobic pathways and further enhance skeletal muscle 
adaptation, perhaps exercise testing should be more specific to these goals.  Most studies 
prescribe interval intensities based on the results of a traditional graded exercise testing which, as 
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discussed previously, may underestimate the intensity that is attainable by this population.  
Anaerobic testing has not been performed extensively in this patient population; therefore, this 
section will focus on the 30 second WAT, which is a valid and reliable test of anaerobic power in 
the healthy population, as well as anaerobic testing in chronic heart failure patients and COPD 
patients.  Since chronic heart failure patients seem to have many of the same limitations as 
COPD patients, it seems likely that their exercise prescription and testing may also be related.  It 
is for this reason that the research using the SR test is also outlined below.    
1.2.5.1  30-Second Wingate Anaerobic Test 
The 30-second WAT has been used for a number of years as an objective measurement of 
anaerobic power and capacity.  The test is easy to administer, non-invasive, inexpensive, and it 
can be tailored for individuals of almost any age and fitness level (Bar-Or, 1987).  It is 
administered by having the individual pedal as quickly as possible before the brake weight is 
applied to the flywheel and then they continue to pedal as hard as possible for 30 seconds.  PWR, 
average work rate and decline of power are the primary outcomes that are evaluated with this 
test.  The WAT is a good test of anaerobic power with a test-retest reliability of r > 0.90 (Bar-Or, 
1987; Vandewalle, Peres, & Monod, 1987).  Bar-Or (1987) reviewed a number of studies 
comparing the 30-second WAT with other tests in an effort to examine the reliability and validity 
of the 30-second WAT.  It is considered a valid anaerobic test based on its comparison against 
several field measurements of activities that are anaerobic in nature, as well as lab tests that 
examine markers of anaerobic work (Bar-Or, 1987).  The 30-second WAT displayed good 
association with sprinting, short distance swimming and the vertical jump (Bar-Or, 1987).  Other 
laboratory tests, including physiological measurements were also compared to the 30-second 
WAT and displayed good correlation (Bar-Or, 1987).  None of the studies that Bar-Or examined 
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can determine validity of the WAT on their own.  However, by examining the studies together, 
one can see that the WAT reflects anaerobic energy utilization (Bar-Or, 1987).   
Originally, the test was administered with a brake weight of 0.075 kp/kg of body weight.  It 
was found through further research that optimal percentages of body weight for brake weight 
were necessary for different groups of individuals.  For example, elite athletes require a heavier 
brake weight than a sedentary individual in order to see an optimal result from the test (Bar-Or, 
1987).  More recently, research has focused on finding optimal brake weights for people of 
different ages, genders, and clinical groups.  Amir et al (2007) tested 59 year old men with the 
30-second WAT with a 4 g/kg brake weight and Bonnefoy et al (1998) used 2.5 g/kg and 4.5 
g/kg as brake weights in their protocol utilizing two 8 second ergometer sprints in elderly men.  
In a similar study, Kostka et al (1997) used 2.5 g/kg and 3.5 g /kg in their 8 second ergometer 
sprints in elderly women.  Since the 30-second WAT has not been used extensively in COPD, it 
was necessary to decide upon the procedure based on the age and gender related studies 
discussed above.  As many COPD patients are elderly, the above recommendations for brake 
weight may be appropriate for this study.  Choosing a brake weight is difficult because the 
desired outcome of the test is a maximal anaerobic effort.  If the brake weight is too heavy, the 
patient may not be able to complete the test.  If the brake weight is too light, it may not 
effectively challenge the muscles for a maximal effort.  
1.2.5.2  Steep Ramp Test 
Recent studies examining exercise testing and prescription in chronic heart failure patients 
have yielded an interesting exercise test meant to elicit a peak power response that may be used 
to prescribe interval training.  Meyer et al (1997) found that chronic heart failure patients could 
exercise at higher intensities than those found using an ordinary incremental ramp test 
 31 
(12.5W/min).  The researchers developed a SR incremental test designed to challenge the 
muscles maximally before the patients reached a cardiovascular limit.  After an unloaded 2 
minute warm-up, the intensity increases by 25 watts every 10 seconds until the patient cannot 
maintain the required speed or their maximum heart rate is attained (Meyer et al., 1996; Meyer et 
al., 1997).  It has been shown in chronic heart failure patients that 50% of PWR on the SR test is 
approximately equivalent to 90-100% PWR of a normal incremental exercise test (Meyer et al., 
1997).  Much higher work rates were achieved with the SR test compared to the ordinary 
incremental ramp test, and a percentage of the PWR found in the SR test was used to prescribe 
intervals for training in this population (Meyer et al., 1997).   
Puhan et al (2006) used the SR test to prescribe interval training intensities in a non-
inferiority study comparing interval exercise to continuous high-intensity exercise in COPD 
patients.  The individuals with COPD performed the SR test with a mean PWR of approximately 
110 watts, while Meyer et al (1996) found that the chronic heart failure patients performed the 
SR test with a similar PWR of 144 watts.  Puhan et al (2006) used the same 12.5 watt/minute 
ramp protocol for the CPET as Meyer et al (1996) and found that 50% of PWR on the SR test 
was equivalent to 90-100% PWR of the CPET in COPD patients, similar to the results using 
heart failure patients reported by Meyer et al. (1996).  Puhan et al (2006) did not evaluate the 
physiological outcomes of the test itself, but rather used it as an anaerobic type of test to 
prescribe intensity for interval exercise.  
Since many of the issues facing chronic heart failure patients and COPD patients are similar 
such as nutrition, muscle pathology, and ventilatory restrictions (Troosters, Gosselink, & 
Decramer, 2004), it may be  reasonable to extrapolate results to the COPD population.  Puhan et 
al (2006) found that COPD patients could also use the SR test with success and it could be used 
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to prescribe interval training.  It appears to be a safe test to use for populations that become short 
of breath quickly during exercise because, rather than being a timed test, it is patient-limited.  
However, an important question remains unanswered: even though the PWR of a SR test may be 
used as a tool for prescribing anaerobic type exercise in chronic heart failure and COPD patients, 
what type of exercise metabolism does the SR test reflect?   
A graphical representation of the tests are presented in Figure 1.4 which displays the slow 
increments of approximately 10 watts/minute of an aerobic power test (the CPET), the 25 
watts/10 second increments of the SR test, and the large power drop from the initial peak power 
of the 30-second WAT. 
1.2.6  Summary 
Traditional aerobic exercise training for rehabilitation seems to be conservative in its 
prescription guidelines in order to respect the dyspnea that patients experience during exertion.  
Gradual increases in intensity have likely been the focus of training in order to prevent excessive 
dyspnea and hypoxia in the ventilatory limited patient.  However, the low gradual work rates 
prescribed for training may not be sufficient to challenge lower extremity muscles.  Although 
decreased muscle strength is multifactorial in nature, strength training helps to address this issue.  
Aerobic and strength training combined may not be sufficient to make maximal gains in exercise 
tolerance that translates into improved quality of life.  Specificity of training should also be 
considered for rehabilitation in this patient population because activities of daily living more 
closely resemble an anaerobic pattern of exercise.  It is difficult to determine exercise intensities 
for interval exercise from the results of a CPET because the PWR may be underestimated due to 
ventilatory limitation.  The SR test has been used to prescribe interval exercise intensities in 
chronic heart failure patients but it is unclear what this test represents in terms of exercise 
metabolism and power output in COPD patients compared to aerobic and anaerobic tests.  Puhan 
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Figure 1.4.  Approximate work rate (watts) achieved over time in the CPET, WAT and SR test.
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used the SR test with COPD patients to prescribe interval training intensities but did not examine 
the physiological characteristics associated with the SR test (Puhan et al., 2006).  Therefore, the 
purpose of this study was to compare the power output and physiological outcomes of the SR test 
to both an anaerobic test (the 30-second WAT) and an aerobic test, such as a CPET, in order to 
estimate the type of energy utilization that the SR test reflects in COPD patients.  The secondary 
purpose was to examine the ventilatory constraint experienced in the SR test compared to the 
other two tests.  
1.3  PROBLEMS AND HYPOTHESES 
1.3.1  Objectives 
1.3.1.1  Determine how the CPET, 30-second WAT and SR test compare in measuring leg power 
in COPD patients. 
1.3.1.2  Determine what type of energy system use is reflected in the SR test. 
1.3.1.3  Determine the effect of significant ventilatory constraint on the outcomes of the CPET, 
30-second WAT and SR test? 
1.3.2  Hypotheses 
1.3.2.1  The PWR on the SR test (SRpeak) and the 30-second WAT average work rate (Wavg) will 
be higher than the PWR attained with the CPET (CPETpeak).  
1.3.2.2  The SR test will reflect anaerobic energy utilization by correlating well with the 30-
second WAT. 
1.3.2.3  The COPD patients will experience less ventilatory constraint at the end of the SR test 
and 30-second WAT, compared to the CPET. 
1.3.3  Assumptions 
It is assumed that the subjects will perform all tests to their maximum ability.  It is also 
assumed that the sample represents the population being studied. 
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1.3.4  Limitations 
This sample of fit elderly COPD patients who were familiar with regular exercise represent a 
small proportion of all COPD patients and may not reflect those individuals who do not exercise 
in a pulmonary rehabilitation program on a regular basis.  This particular sample of patients also 
do not rely on supplemental oxygen at rest or during exercise which further narrows the ability to 
apply the results to a larger population.  Less than maximal effort from the subjects could 
underestimate the outcomes of the tests.  Small errors in recording mechanical, metabolic and 
ventilatory variables may affect results.  Small sample size decreases power and may restrict 
evaluation of the results stratified into gender and severity of disease.   
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CHAPTER 2 
METHODS 
2.1  SUBJECTS 
12 patients (8 males and 4 females) with COPD were recruited through the Saskatoon 
Pulmonary Rehabilitation Program and through the Division of Respirology, Critical Care and 
Sleep Medicine, University of Saskatchewan.  One patient was excluded because the inclusion 
criteria for impairment of lung function of FEV1/FVC < 0.7 was not met at the screening visit.  
The remaining 11 patients completed the study.  The subject characteristics are presented in 
Table 2.1. 
This research was approved by the University of Saskatchewan Biomedical Ethics 
Committee.  All subjects signed a consent form (Appendix 1) and were advised that they could 
freely withdraw from the study at any time. 
2.1.1  Inclusion Criteria 
A previously confirmed diagnosis of COPD as defined by ATS/ERS, Canadian Thoracic 
Society, and GOLD spirometric classification of disease (Celli BR. MacNee W. ATS/ERS Task 
Force, 2004; O'Donnell et al., 2008; Rabe et al., 2007), defined as post-bronchodilator 
FEV1/FVC <0.7 (Figure 1.3).  FEV1/FVC is a ratio of the amount of air forcibly exhaled in one 
second (FEV1) compared to the vital capacity forcibly exhaled (FVC) (O'Donnell et al., 2008).  
Obstructive lung disease is characterized by a decreased FEV1 and a normal or increased FVC, 
which leads to a decreased FEV1/FVC ratio (O'Donnell et al., 2008).  Varying degrees of 
severity of COPD are classified by evaluating the FEV1.  FEV1 ≥80% predicted indicates mild  
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Table 2.1: Subject characteristics 
   
Subject Characteristics (n=11)  
  
Male:Female % 64:36 
Age (years) 71 ± 3 
Weight (kilograms) 84.6 ± 21.0 
BMI (kg/m2) 29.3 ± 5.9 
TLC (liters) 6.56 ± 1.21 
FEV1 (% predicted) 1.08 ± 0.26 (43 ± 15) 
FVC (% predicted) 2.73 ± 0.68 (83 ± 15) 
FEV1/FVC 41.00 ± 10.26 
Abbreviations: TLC = total lung capacity, FEV1 = forced expiratory volume in 1 second, FVC = 
forced vital capacity, pred = predicted. 
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disease, FEV1 of 50-79% predicted indicates moderate disease, 30-49% of predicted indicates 
severe disease and below 30% is considered very severe disease (O'Donnell et al., 2008).  
2.1.2  Exclusion Criteria 
1.  Acute exacerbation of COPD requiring hospital admission within the previous 6 weeks. 
2.  Requirement for supplemental oxygen at rest or during exercise. 
3.  Current known or suspected cardiac disease that would prevent patient from completing 
heavy exercise. 
4.  Use of beta blockers, which may limit or blunt the heart rate response to exercise. 
5.  Neuromuscular disease, stroke, vasculitis or severe arthritis, which would restrict maximal 
use of lower extremities. 
6.  Any lower extremity injury that may be exacerbated by testing, or may impair exercise 
responses. 
2.2  RESEARCH DESIGN 
A randomized cross-over design was used to test subjects’ physiological responses to the 30 
second WAT and the SR test.  The subjects attended 3 sessions for testing, within a 3 week 
period, with at least 48 hours separating sessions.  An initial baseline assessment session 
included pulmonary function tests and a CPET.  The following 2 visits each included a 30 
second WAT and a SR test separated by one hour.  The second of these 2 visits was included in 
order to establish the reliability of these measures.  The order of the tests was constant between 
visits but randomized between subjects.  The subjects’ order of tests was randomized in pairs in 
order to control for variation in the case that 1 hour between tests was insufficient for recovery.  
The odd numbered subjects’ order of tests was randomized while the corresponding even 
numbered subjects’ order of tests was reversed. 
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2.3  PROCEDURES 
2.3.1  Pulmonary Function Testing 
Resting pulmonary function testing was performed according to the ATS/ERS standards and 
guidelines (Miller MR et al., 2005; Miller MR, Hankinson J et al., 2005; Wanger J et al., 2005) 
using a V6200C Autobox and Vmax 229D gas analyzer manufactured by SensorMedics Corp., 
Yorba Linda, California, USA.   Measures obtained included FEV1, FVC, inspiratory capacity 
(IC), VT, VE, RR, and TLC.  FEV1 and FVC are necessary for classifying impairment of lung 
function, and TLC and IC is used to compute EELV, IRV and end-inspiratory lung volume 
(EILV).  Diffusing capacity of the lung for carbon monoxide (DLCO) was not measured due to 
technical issues with the measurement system. 
2.3.2  Maximal Incremental Cardiopulmonary Exercise Test 
The CPET or VO2max test, is an incremental test performed on a cycle ergometer that 
measures the maximum amount of oxygen consumption, or aerobic capacity (American College 
of Sports Medicine, 2006; American Thoracic Society & American College of Chest,Physicians, 
2003).  The test is considered physiologically maximal if any of the following occur: maximal 
heart rate is achieved, a plateau in oxygen uptake is observed, respiratory exchange ratio (RER) 
> 1.15, and the patient states that they believed it was a maximal test (American College of 
Sports Medicine, 2006; American Thoracic Society & American College of Chest,Physicians, 
2003).  Often patients with COPD do not reach maximum according to these guidelines because 
their ventilatory limitation stunts the progression toward a maximal heart rate and oxygen uptake 
response.  The test still provides useful information regarding the patient’s response to exercise 
and their ventilatory limitation. 
The CPET was performed on a mechanically braked cycle ergometer (800S, SensorMedics) 
and physiological measurements were obtained using the gas analyzer (Vmax 229D, 
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SensorMedics).  The intensity of the increments (5-20 watts per minute) was set by the 
supervisor according to experience and the patient history in order to illicit an exercise duration 
of 6-8 minutes (American Thoracic & American College of Chest,Physicians, 2003).  Blood 
pressure, heart rate, oxygen saturation (SpO2), RPE for dyspnea and fatigue, and IC were 
recorded every 2 minutes.  3-lead ECG readings were recorded at baseline, end-exercise and at 
any point where the rhythm showed any abnormalities.  Physiological parameters such as VO2, 
VCO2, RER, VT, VE, and RR were recorded on a breath by breath basis and were averaged in 10 
second increments.  IC was also recorded within 15 seconds of the end of exercise.  The subjects 
were encouraged to cycle until they could not continue. The test was terminated when the subject 
indicated they could not carry on, or the revolutions per minute fell 10 below the required level. 
Criteria for stopping an exercise test prematurely included abnormal blood pressure 
responses, deteriorating heart rhythm abnormalities, lightheadedness, nauseousness, chest pain, 
or the subject wished to stop the test. 
2.3.3  30 Second Wingate Anaerobic Test 
Subjects were fitted for comfort on the cycle ergometer (Monark 894 E, Ergomedic) and the 
test was explained in detail. The subjects completed a self paced 5 minute warm-up with no 
resistance applied to the flywheel in order to warm-up the lower extremity muscles without 
taxing the ventilatory system.  The start of the test was practiced twice so that the subject was 
used to the procedure of attaining maximal speed within a few seconds.  The brake weight 
applied during the practice starts was half of the brake weight used for the actual test.  
Precedence for practicing with different brake weights for a few seconds was found in studies by 
Kostka et al (1997) and Bonnefoy et al (1998) but the intensity was not specified.  The practice 
brake had to be heavy enough to be realistic, but not so heavy as to tire the subject. 
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Patients were fitted with the headgear used to hold the pneumotach and were also monitored 
by oximeter and 3-lead ECG.  Baseline resting ventilatory data, such as IC, were recorded by the 
Vmax software and select parameters such as HR, SpO2, RPE, and blood pressure were recorded 
manually in the chart.  Patients were asked to pedal as fast as they could and as soon as they 
reached maximal velocity, the brake weight was applied to the flywheel.  Patients tried to 
maintain the maximal velocity for 30 seconds.  Continual encouragement was given to the 
patient throughout the entire test.  Ventilatory parameters were monitored as during the CPET 
using the SensorMedics analyzer as described above.  Borg RPE for dyspnea and leg fatigue, and 
IC were recorded at end exercise. 
The principal outcome for the 30-second WAT is the average power output over the entire 30 
seconds of the test.  The peak power is usually attained in the first few seconds and therefore, 
may indicate the peak power that the leg muscles may produce for a very short amount of time.  
In contrast, the average power may indicate the peak anaerobic power that the leg muscles may 
be able to sustain for more than a few seconds (Bar-Or, 1987).  The peak power may be more of 
an indication of the capacity of the alactic anaerobic system rather than a measurement of the 
ability of the anaerobic system to manage work for more than 10 seconds (Bar-Or, 1987). 
As outlined in the background, the brake weight used for these subjects was not the usual 
75g/kg.  The brake weight for females was 35g/kg (Kostka et al., 1997) and the brake weight for 
males was set at 45g/kg (Bonnefoy et al., 1998) due to the decreased muscle mass, strength and 
cardiopulmonary ability that is often seen in this population.  There was one male subject that 
had a brake weight calculated at 35g/kg because he had a combined issue of being overweight 
and had very poor ventilatory status.  
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2.3.4  The Steep Ramp Test 
The protocol for the SR test developed by Meyer et al  (1996) was replicated for this study.   
The test was performed using the same equipment that was used for the CPET.  Ventilatory 
information and vitals were monitored as per the 30-second WAT.  After a 2 minute unloaded 
warm-up, the intensity increased by 25 watts every 10 seconds.  Borg RPE and IC were obtained 
at the beginning and end of the test.  The test was terminated when the subject indicated they 
could no longer continue or if the revolutions per minute fell 10 below the required level.  The 
PWR was recorded for use in the analysis. 
2.3.5  Between Test Protocol 
Subjects were instructed not to eat or drink anything other than water for the hour in between 
the WAT and SR tests.  Slow walking was encouraged, and subjects were permitted to rest if 
they were fatigued.  
2.4  MEASURES 
2.4.1  Inspiratory capacity 
Measuring IC during testing is an indirect way of detecting EELV and IRV and the degree of 
ventilatory constraint that the patient experiences.  The technique of measuring inspiratory 
capacity during exercise has been shown in the literature to be valid and reproducible in COPD 
patients (Yan, Kaminski, & Sliwinski, 1997; O'Donnell, Lam, & Webb, 1998).  During exercise, 
the patient is asked to perform a maximal inspiration following normal expiration.  The flow and 
volume is recorded by the metabolic cart and stored in the computer with the physiological 
measurements for each patient.  EELV can be found by subtracting the IC from TLC.  The 
patients’ IRV can also be found by subtracting VT from the IC.  These measurements are an 
indication of the amount of dynamic hyperinflation that occurs during exercise (See Figure 2.1). 
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Figure 2.1.  Diagram of lung volumes
 44 
VT/IC gives the percentage of the remaining IC that is being used as VT, which is also a 
measurement of ventilatory constraint (O'Donnell, Revill, & Webb, 2001). 
IC was obtained at baseline, every 2 minutes during the CPET and within 15 seconds of the 
end of the tests.  The subjects were familiarized with the examiner’s cueing for IC before testing 
began each day.   
2.4.2  Oxygen saturation 
SpO2 and heart rate were measured by a finger pulse oximeter (N-395, Nellcor). 
Measurements were taken at baseline, during exercise and during recovery and were recorded 
electronically by the metabolic cart and also manually recorded in the chart.  Exercise was 
terminated if SpO2 fell below 85%. 
2.4.3  Heart rate and rhythm 
A 3-lead electrocardiogram (ECG) was used to evaluate heart rhythm and provide 
confirmation of heart rate.  Recordings of ECG tracings were saved electronically during 
baseline, recovery, and at any time during exercise when any rhythm abnormalities were noticed.  
Exercise was terminated if there were ischemic ECG changes, or a dysfunctional heart rhythm 
that was not congruent with exercise.  For example, if occasional premature ventricular 
contractions converted to frequent couplets, trigeminy or bigeminy, the exercise test would be 
terminated immediately. 
2.4.4  Blood pressure 
Blood pressure recordings were taken manually before and after exercise testing as well as 
every 2 minutes during the CPET.  Exercise was terminated if systolic blood pressure was >250 
mm Hg, diastolic pressure was >120 mm Hg, or if there was a fall in systolic pressure >20 mm 
Hg from the highest value during the test. 
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2.4.5  Subjective symptoms 
The patients were asked to report their perceptions regarding, 1) their level of dyspnea and 2) 
their level of leg fatigue.  These 2 separate ratings of perceived exertion (RPE) were recorded 
using a 0-10 modified Borg scale at the beginning and at the end of each test (see Figure 2.2).  
RPE was also recorded every 2 minutes during the CPET.  The patients were asked the same 
questions in the same order each time to maintain consistency: “How short of breath do you 
feel?” and “How tired are your legs?”  The patients were unable to speak with the mouthpiece in, 
so they pointed to the corresponding number that matched the severity of their symptom after 
each of the above questions. 
2.4.6  Ventilation During Exercise 
Ventilation was monitored throughout all tests to determine the changes over time and end-
exercise ventilatory limitations.  VT and VE are dynamic during exercise so it is important to 
monitor them over time to track changes.  The VO2 and carbon dioxide elimination (VCO2) is 
monitored to track changes in metabolism during exercise.  The RER is the amount of CO2 
produced divided by the amount of consumed oxygen.  That ratio is an estimate of what 
substance the body is primarily using for fuel at any given time during exercise.  It can also be an 
indicator of exhaustion towards the end of a VO2max test when the value is over 1 and is 
approaching 1.2 (American College of Sports Medicine, 2006).   
2.5  STATISTICAL ANALYSIS 
Due to the small sample size, all variables of interest were tested for normality using the 
Shapiro-Wilk test (Shapiro & Wilk, 1965), which is a good test of normality for samples n<20.  
IRV% and EILV% for all 3 tests were found to be not normally distributed; therefore, 
examination of these variables included non-parametric analysis.  The remaining variables were 
analyzed using parametric statistics.
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10 Maximal 
9 Very, very severe (almost maximal) 
8  
7 Very severe 
6  
5 Severe 
4 Somewhat severe 
3 Moderate 
2 Slight 
1 Very slight 
0.5 Very, very slight 
0 None 
 
Figure 2.2.  0-10 Modified Borg scale used to measure subjective perceptions of both dyspnea 
and leg fatigue (Burdon, Juniper, Killian, Hargreave, & Campbell, 1982).
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All statistical analysis was performed using a significance level of p<0.05 unless otherwise 
stated.  The analysis of the data included repeated measures analysis of variance (ANOVA) 
comparing the CPETpeak, SRpeak, and the Wavg.  Tukey’s post-hoc analysis was performed where 
appropriate.  Pearson r correlations between the above measures were also completed to measure 
the strength of the relationships. 
Ventilatory and metabolic results at peak exercise were also analyzed using repeated 
measures ANOVA.  The measures that did not satisfy the assumption of normality as described 
previously were analyzed with Friedman’s test.  Reliability of the SR and the WAT was analyzed 
using Bland-Altman plots. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
3.1  RESULTS 
3.1.1  Analysis 
3.1.1.1  Between test differences 
The analysis revealed significant differences in work rate between the 3 tests.  The CPETpeak 
was found to be lowest, followed by SRpeak and then Wavg (65.90 ± 35.90 W, 156.81 ± 67.86 W 
and 231.15 ± 113.36 W) (See Figure 3.1).  The time to complete each of the tests was also 
evaluated.  The CPET was the longest test, then the SR followed by the WAT (6.36 ± 2.36 min, 
1.12 ± 0.45 min, 0.5 min). 
The differences in physiological parameters measured in each of the tests were analyzed to 
determine the differences in peak exercise metabolism and ventilation.  There were no significant 
differences found between VO2, RR, SpO2 or VE measurements at peak exercise in each of the 3 
tests.  IC, IRV and EELV at end exercise, expressed as percentages of TLC (IC%, IRV% and
EELV%, respectively), also did not show any difference.  Similarly, VT expressed as a 
percentage of IC (VT/IC%) at end exercise was not significantly different between the 3 tests.  
VCO2 at peak exercise (VCO2peak) in the CPET was higher than VCO2peak in the WAT (1.129 ± 
0.522 L/min and 0.895 ± 0.422 L/min).  VCO2peak in the SR test (0.973 ± 0.399 L/min) was not 
significantly different from the other 2 tests.  The RER at end exercise in the CPET (0.999 ± 
0.125) was higher than both the SR and the WAT (0.898 ± 0.066 and 0.888 ± 0.079).  However, 
the RER was not significantly different between the SR and the WAT.  There was a significant
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Figure 3.1:  Comparison of the cardiopulmonary exercise test peak power (CPET), the steep 
ramp test peak power, and the average power in the 30-second Wingate anaerobic test in watts.  
Results are presented as mean ± standard deviation. 
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 difference between the WAT (7 ± 2) and the SR (5 ± 2) RPE for dyspnea.  There were no 
differences in RPE in regards to leg fatigue between the tests.  Between test data are presented in 
Table 3.1. 
3.1.1.2  Correlations 
Pearson r analyses of work rates revealed significant correlations between SRpeak and both the 
CPETpeak and the Wavg (r = 0.887 and 0.887 respectively).  CPETpeak and Wavg were also found to 
have a significant correlation (r = 0.795). 
Many ventilatory parameters for the SR were found to correlate significantly with the CPET 
and WAT such as VO2  (r = 0.891 and 0.939), VCO2 (r = 0.837 and 0.926), VT (r = 0.907 and 
0.954), EELV% (r = 0.905 and 0.873), and IRV% (r = 0.916 and 0.880).  VEpeak also correlated 
well with its respective power output for each of the tests (CPET r = 0.855, WAT r = 0.797, SR  
r = 0.940).  RER on the SR correlated with RER on the WAT (r = 0.615). 
3.1.1.3  Reliability 
     The WAT and the steep ramp test were both performed twice to ensure the data was reliable.  
Wavg and SRpeak correlate well from one day to the next (r = 0.966 and 0.991 respectively), and 
Bland-Altman plots were used to determine the equality of the data and the magnitude of 
differences in measurements between the 2 sessions (See Figures 3.2 and 3.3).  Means and 
standard deviations of the work rates are presented in Table 3.2. 
3.1.2  Power Analysis 
     Study sample size analysis focused on the power outputs for each of the tests.  Since the SR test 
was of principal interest in this study, it was compared to each of the other tests separately with a 
2 sample comparison of means to determine power of the study.  When the SRpeak and WATavg 
are used in a two-tailed test of significance, the power of the study is 46.3%.  When the SRpeak
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Table 3.1: End-exercise measures for cardiopulmonary exercise test (CPET), steep ramp test 
(SR), and Wingate anaerobic test (WAT) presented with means and standard deviations. 
End-Exercise Measures Tests 
 CPET SR WAT 
PWR (CPET & SR) Wavg (WAT) 65.9 ± 35.9 156.8 ± 67.9*† 231.2 ± 113.4* 
VO2 (L/min) 1.11 ± 0.46 1.07 ± 0.41 0.99 ± 0.45 
VCO2 (L/min) 1.13 ± 0.52 0.97 ± 0.40 0.90 ± 0.42* 
VE (L/min) 40.4 ± 13.3 38.9 ± 13.0 39.7 ± 14.7 
RER 1.00 ± 0.13 0.90 ± 0.07* 0.89 ± 0.08* 
VT (L) 1.19 ± 0.31 1.12 ± 0.24 1.09 ± 0.33 
VT/IC (%) 76.5 ± 13.0 70.1 ± 12.0* 70.4 ± 13.8 
IC/TLC (%) 24.1 ± 4.7 25.1 ± 5.5 23.5 ± 4.0 
EELV/TLC (%) 75.9 ± 4.7 74.9 ± 5.5 76.5 ± 4.0 
EILV/TLC (%) 94.0 ± 4.7 92.0 ± 5.1 92.9 ± 4.2 
IRV/TLC (%) 6.0 ± 4.7 8.0 ± 5.1 7.1 ± 4.2 
RR (breaths per minute) 34 ± 6 35 ± 8 37 ± 8 
SpO2 (%) 91.5 ± 3.0 92.3 ± 1.5 93.3 ± 3.9 
*indicates significant difference from CPET. †indicates significance from WAT. PWR=peak work rate, 
VO2=oxygen consumption, VCO2=carbon dioxide elimination, VE=minute ventilation, RER=respiratory exchange 
ratio, VT=tidal volume, IC=inspiratory capacity, TLC=total lung capacity, EELV=end expiratory lung volume, 
EILV= end inspiratory lung volume, IRV=inspiratory reserve volume, RR=respiratory rate, SpO2=oxygen 
saturation. 
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Figure 3.2.  Bland-Altman plot of reliability of Wingate average power measurements (Wavg) 
between both sessions.  Y-axis: The difference between Wavg from one day to the next.  X-axis: 
The average of Wavg between both days. 
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Figure 3.3.  Bland-Altman plot of reliability of the steep ramp peak power measurements 
(SRpeak) between both sessions.  Y-axis: The difference between SRpeak from one day to the next.  
X-axis: The average of SRpeak between both days.
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Table 3.2:  Correlation of work rates recorded over 2 sessions presented with means and 
standard deviations.   
 Wingate Average Power Steep Ramp 
Day 1 (watts) 237.2 ± 119.1 159.1 ± 70.1 
Day 2 (watts) 225.2 ± 109.6 154.6 ± 66.0 
Pearson r correlation 0.966 0.991 
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is used in conjunction with the CPETpeak in a one-tailed test of significance, the power of the 
study is 98.9%.  Although these results are very dissimilar, they reflect the vast differences in the 
standard deviations for each of the tests.  The CPET used in combination with the steep ramp test 
indicates good power because it would not be difficult to assess differences between these means 
with low standard deviations.  The reverse is true when considering the steep ramp with the 
WAT because of the large mean and standard deviation associated with the WAT. 
3.2  DISCUSSION 
3.2.1  Introduction 
The purpose of this study was to compare the power outputs and physiological outcomes 
between the tests and determine if the steep ramp test better reflects aerobic or anaerobic 
exercise in COPD patients.  The findings illustrate that higher power output is achieved in the SR 
and WAT compared to the CPET (156.8 ± 67.9, 231.2 ± 113.4, 65.9 ± 35.9 W respectively), 
while there are no differences in VO2, VE, IC%, IRV% and RR during the 3 tests.  These 
findings indicate that similar ventilatory restrictions exist for all 3 tests despite the different work 
rates attained.  Although SRpeak and Wavg correlate well with each other, they also both correlate 
with the aerobic CPETpeak.  These findings together suggest that performance on the 3 tests is 
more reflective of the degree of ventilatory limitation attained, than of the type of energy system 
utilized.  Nonetheless, the short amount of time to complete the SR test (67 ± 27 seconds) 
(American College of Sports Medicine, 2001) and the high power output suggests that the SR is 
a reasonable test of anaerobic power despite the ventilatory limitations.  
3.2.2  Peak work rate    
This study supports the assertion that leg power is often underestimated in the traditional 
incremental design of the CPET and is frequently terminated before a maximal muscular 
response has been achieved due to ventilatory limitations (Butcher & Jones, 2006; Vogiatzis et 
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al., 2004; Vogiatzis et al., 2005; Meyer et al., 1996).  The first hypothesis is supported by the fact 
that the CPET produced the lowest work rate followed by the SR and WAT respectively.  
According to the findings, prescription of exercise intensities of 100% CPETpeak (66 ± 35 W) is 
not quite 50% of the SRpeak (SR50%) scores (78 ± 34 W).  This is comparable to the findings of 
Meyer et al (1997) that SR50% is approximately equivalent to 90-100% CPETpeak in chronic heart 
failure patients.  The variation in findings may be related to differences between the diseases or 
the severity of the cardiopulmonary limitations between groups.  In this sample, prescription of 
100% CPET PWR for interval training underestimates what is achievable by these patients.  
Ideal intensities for interval training are unknown for this population, but if 60-70% of the SRpeak 
was appropriate for intensity prescription then the CPET falls short of being useful.  If exercise 
prescription is based on the measure of maximal leg power achieved during a test, then testing 
should more accurately reflect what the patient is capable of accomplishing. 
The Wavg was significantly larger than the SRpeak and may be partially related the design of 
the tests.  The WAT includes more speed and momentum at the beginning of the test, and the SR 
uses increments to ramp up to maximal power.  The high speed and momentum at the beginning 
of the WAT encourages high peak power and facilitates continued work to the end of the 30-
second test, thus driving up the average power.  In contrast, the SR builds incrementally from 
25W, at a relatively slow rate, to a patient limited maximum. It is difficult to determine the exact 
contribution of each energy source (PCr, glycolysis, or aerobic metabolism) during exercise.  
However, maximal exercise is still primarily fueled by anaerobic glycolysis at approximately 60 
seconds (American College of Sports Medicine, 2001).  The average time to complete the SR 
test was approximately 60 seconds (67 ± 27 seconds) and therefore the test may be assumed to 
be predominantly anaerobic in nature. 
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The second hypothesis appears to be supported by the significant correlations between the SR 
and the WAT in regards to power output (r = 0.887) despite the mean differences in power found 
between the tests.  However, the hypothesis is ultimately not supported because the CPET also 
correlates well with the SR and the WAT (r = 0.887 and 0.795 respectively) despite producing 
the lowest power output and being a test of aerobic, rather than anaerobic, power.  This 
illustrates that the correlations may not indicate a similarity between the tests in regards to the 
predominant energy system.   
3.2.3  Limitations of ventilation 
The fact that the patients reached similar maximal ventilation in all 3 tests was not 
anticipated, and does not support the third hypothesis.  Ventilatory constraint at end-exercise is 
indicated by an inability to increase VT due to dynamic hyperinflation (O'Donnell, Revill, & 
Webb, 2001), and by nearing predicted maximal ventilation   EELV and EILV increase, IRV 
decreases, and an increasing VT during exercise occupies a large percentage of IC (O'Donnell, 
Revill, & Webb, 2001).  It was assumed that the patients would be limited by ventilatory 
constraint during the CPET, in part due to the relatively long period of time they were exercising.  
Therefore, it was also assumed that they would hyperinflate less, demonstrate less ventilatory 
constraint (ie. increased ventilatory reserve), and be limited more by peripheral muscle 
performance during tests lasting only 30-90 seconds.  However, despite the varying exercise 
durations, the similar level of ventilatory restriction observed in the 3 tests suggests this may be 
the limiting factor in all of the tests.  This common limitation may be the reason why there are 
significant Pearson r correlations between CPETpeak, SRpeak and Wavg (SRpeak vs CPETpeak r = 
0.887, SRpeak vs Wavg r = 0.887, CPETpeak vs Wavg r = 0.795). 
There were no differences in the separate measurements of IC% and VT between the tests.  
However, the combination of the CPET’s slightly smaller IC% and a slightly larger VT, 
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compared to the SR, translates into a statistically significant difference in the percentage of IC 
used as VT (76.47 ± 12.98% and 70.06 ± 11.95% respectively).  The absolute difference of 
approximately 52 milliliters is not clinically important as demonstrated by the similar RPE for 
dyspnea recorded between the CPET and SR (6 ± 2 and 5 ± 2, respectively).  Taken together 
with other lung volume measurements, this finding suggests no difference in ventilatory 
constraint between the CPET and SR. 
The previous studies that have used the SR test (Meyer et al., 1996; Meyer, Schwaibold et al., 
1996; Meyer et al., 1997; Puhan et al., 2006) have not evaluated lung volumes and dynamic 
hyperinflation during the test.  Meyer et al (1996, 1996, 1997) used the SR test with chronic 
heart failure patients who become short of breath during exercise due to the inefficiency of the 
heart to pump blood; therefore, lung volumes were likely not outcomes of interest.  Puhan et al 
(2006) used the SR test for COPD patients, but the test was used to set intensities for interval 
training rather than evaluating lung hyperinflation.   
It is difficult to compare these results with prior work as there is a paucity of research 
examining lung volumes during short-term exercise tests in COPD.  Interval training studies may 
allow some comparison because the work intervals approximate the time it takes to complete the 
WAT and SR.  Vogiatzis et al (2004) used 30 second intervals in their study of COPD patients 
and found a higher IRV at end-exercise during interval exercise compared to continuous 
exercise.  This is not similar to the findings of this study since subjects in both the SR and the 
WAT had very little IRV remaining at end-exercise.  However, Vogiatzis et al used 100% PWR 
based on a typical incremental exercise test.  The higher work rates attained using the SR and 
WAT in this study may have contributed to increased hyperinflation. Also, if end-exercise 
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measures in the Vogiatzis study were obtained at the end of a rest interval, it is possible that IRV 
had increased as the patient recovered from peak exercise. 
3.2.4  Metabolic outcomes 
Oxygen debt recovery by the aerobic system is necessary in order to replace the ATP that has 
been depleted by maximal anaerobic exercise, or exercise that has exceeded the anaerobic 
threshold (American College of Sports Medicine, 2001).  The high levels of lactic acid must be 
buffered in order to restore the body to a less acidic state.  The respiratory system acts quickly by 
releasing more CO2 to assist this process (American College of Sports Medicine, 2001).  The 
high VCO2peak in the CPET (1.13 ± 0.52 L/min) is likely an indication of the patients exceeding 
anaerobic threshold towards the end of a relatively long period of exercise of increasing 
intensity.  The VCO2peak in the WAT (0.90 ± 0.42 L/min) is the lowest of the 3 tests which may 
be an indication of the pH buffering just beginning to occur in that short time period.  The steep 
ramp VCO2peak (0.97 ± 0.40 L/min) seems to fall in between the other 2 values, and although not 
significant, would seem to indicate that despite the fact that the steep ramp test was much shorter 
in duration than the CPET, the higher work rate may have contributed to an increase in the 
anaerobic system’s contribution towards the end of exercise.  Also, the increased time of the SR 
may have allowed enough time for buffering to occur.  The short duration of the WAT may have 
contributed to the lower VCO2peak recorded during that test.  If VCO2peak was recorded even a 
few seconds after completion of the WAT, there may have been more time for the body to fully 
buffer the lactic acid and the values may have been similar to the SR or CPET.  Despite the 
significant difference in VCO2peak between the CPET and the WAT, there were no significant 
differences in RER between the 3 tests.  The correlation of RER between the SR and the WAT 
(r= 0.615) reflects the similarities in metabolic measurement at peak exercise between the two 
tests.  However, as discussed above, if measurements were taken just a few seconds after the 
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completion of the WAT then perhaps VCO2peak and VO2peak – and thus RER – measurements 
would have been more similar to the SR and the correlation may have been higher. 
Although RR and SpO2 were the same between tests at end exercise, an anecdotal observation 
was that SpO2 often decreased slightly during recovery of the steep ramp and more so during the 
WAT.  Given the ventilatory limit that was achieved at end exercise in all 3 tests, and the fact 
that the patients had an inability to increase ventilation much further at that point, it is not 
surprising that SpO2 would begin to decrease as the body tried to overcome the oxygen debt 
sustained during anaerobic exercise.  Patients could more easily recover from the CPET, a slow 
incremental test, because they could stop when they felt themselves approaching maximum 
effort.  With anaerobic exercise, once the short period of intense exercise is over, the body must 
replace the spent ATP and rid itself of waste products (American College of Sports Medicine, 
2001).  Ventilation must increase as a result of lactic acid buffering during recovery and if the 
patient is already at their maximum ventilation, they face a difficult recovery even after they 
have stopped exercise.   
Collection of recovery data may have provided meaningful data in order to understand the 
metabolic and ventilatory changes during the period of recovery from oxygen debt.  
Unfortunately, the patients became somewhat claustrophobic at the end of exercise when they 
were struggling to catch their breath.  The need to reduce anxiety in order to assist the patients to 
recover safely became paramount and the breathing apparatus was removed.  
Although similar ventilatory constraint was found between all 3 tests, the RPE for dyspnea 
was significantly higher for the WAT than the SR test.  This may be a reflection of the difficult 
recovery observed after the WAT.  Logistical issues such as removal of the breathing apparatus 
and patient anxiety and exhaustion made it impossible to ask the patients about their RPE right at 
 61 
the end of exercise for the WAT.  The patients were asked approximately 30 seconds-1 minute 
after the end of the test to comment on their end of test dyspnea and leg fatigue, which may have 
been tainted by their difficult experience of oxygen debt recovery during the delay.  
3.2.5  Limitations  
There are a few limitations to this study.  There were many exclusion criteria so the results 
may not be generalized to those individuals who would have been excluded according to the 
criteria set out in Chapter 2.  Many COPD patients use supplemental oxygen at rest or during 
exercise which could have altered results or helped them to recover more easily from the 
exercise tests compared to those patients who do not use supplemental oxygen.  That exclusion 
criterion on its own severely limited the sample from which to draw subjects. 
According to the classification of lung function impairment discussed in chapter 2, there were 
2 patients in this study with moderate impairment, 8 patients were defined as having severe 
impairment, and 1 patient had very severe impairment.  Therefore, since most of the subjects had 
at least severe impairment of lung function, these results may only be generalized to that 
classification of patients.  Also, these trained patients were recruited from a pulmonary 
rehabilitation program where they were familiar with exercise and desensitized to fatigue, pain 
and dyspnea.  They were comfortable with their limitations and were perhaps not as anxious as 
other unconditioned patients may have been. 
 
 62 
CHAPTER 4 
CONCLUSIONS 
4.1  SUMMARY 
The findings of this study indicate that, patients with COPD elicit similar degrees of 
ventilatory constraint during the SR test as in both the CPET and WAT tests, despite the 
significantly different power outputs obtained across the 3 tests.  The power output on the SR, 
albeit statistically lower than the average power on the WAT and the short duration of the SR 
test suggest that peak SR power best reflects anaerobic power.  Meyer et al (1996, 1996, 1997) 
have presented the SR test as a useful tool to prescribe interval training intensities, but it had  not 
previously been evaluated against both aerobic and anaerobic tests to determine the type of 
exercise energy system it reflects.  Furthermore, it has not previously undergone analysis in 
regards to lung volume measurements in COPD patients.   
The traditional CPET used to test COPD patients has many uses, but it appears to be 
imprecise in assessing peak power capabilities of the lower extremity muscles.  More recent 
literature has focused on prescribing higher work rates for aerobic exercise in the form of 
interval training.  Patients are able to perform the same amount, or more total work, than 
continuous exercise with fewer symptoms.  CPETpeak, or a high percentage of CPETpeak has been 
used to prescribe intensity.  However, the low work rates achieved in the CPET may 
underestimate the patients’ abilities for interval exercise.  A test of anaerobic power may be more 
suitable for prescribing interval exercise in order to increase the potential for training benefit in 
COPD patients. 
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The highest PWR was found in the WAT but the patients found the test to be especially 
demanding.  Patients typically control their effort by monitoring their shortness of breath during 
exercise but by the nature of anaerobic exercise, that is not possible with the WAT.  The patients 
gave maximal effort during the test without realizing the degree of dyspnea they would incur as 
they tried to overcome the oxygen debt at the end of exercise.  The SR test seems to be an 
appropriate compromise between the low PWR of the CPET and the high PWR, but demanding 
recovery, of the WAT.  The SR test reflects anaerobic type power while allowing the patients to 
manage their symptoms. 
Interval training is attractive for those patients who become very short of breath during 
aerobic exercise.  Pulmonary rehabilitation programs will likely follow the more recent research 
and begin to use interval training in an effort to improve the fitness of their participants.  It 
allows patients to improve their fitness dramatically with similar, or decreased, symptoms.  
Anaerobic training may be used as an adjunct to aerobic endurance training but likely should not 
replace it completely in pulmonary rehabilitation.  The CPET is therefore still useful for 
determining baseline status, determining the cause of exercise limitation, and prescribing aerobic 
exercise.  The SR test is a useful clinical test for prescribing anaerobic interval intensity.  
However, the WAT is very difficult for patients and should likely be used in select situations.    
Further research is required to determine what percentage of SRpeak may be tolerated in 
interval training.  Other research may focus on determining protocols for interval training in 
COPD including, duration of work and rest intervals, intensity of resting intervals, overall 
exercise time, and number of workouts per week.   
4.2  CONCLUSIONS 
4.2.1  Hypothesis 1.3.2.1 (The SR test PWR and the 30-second WAT average work rate will 
be higher than the CPET PWR.) was supported by the experimental evidence.  The work rates 
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were significantly different from each other with the Wavg and SRpeak being higher than the 
CPETpeak. 
4.2.2  Hypothesis 1.3.2.2 (The SR test will reflect anaerobic energy utilization by correlating 
well with the 30-second WAT.) was not ultimately supported due to the fact that all 3 tests 
correlated well with each other.  The correlation may not be an indication of the similarity of 
energy systems expressed during exercise. 
4.2.3  Hypothesis 1.3.2.3 (The COPD patients will experience less ventilatory constraint at the 
end of the SR test and 30-second WAT, compared to the CPET.) was not supported by the 
evidence.  The patients experienced a similar level of ventilatory constraint in all 3 tests. 
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APPENDIX 1 
CONSENT FORM 
Leg Muscle Power in Patients with COPD: An Examination of High Intensity 
Exercise Testing Protocols 
 
CONSENT FORM 
 
• I have read and I understand the information presented in this form.   
• I have had the purpose, procedures and technical language of this study fully explained to 
me.  I have been given ample time and opportunity to consider the above information, to 
inquire about details of the study and to decide whether or not to participate. 
• Having read all pages of this information and consent form and understanding the 
requirements of the study, my signature below indicates that I voluntarily consent to 
participate in this study. 
• I understand that I will receive a copy of this information and consent form. 
 
• Please check the appropriate statement to indicate your decision:   
                My family physician can be informed about my participation in this study, and, if 
required, consulted regarding my health and treatment. 
      or 
                My family physician cannot be informed about my participation in this study, 
and, if required, consulted regarding my health and treatment. 
 
_____________________________________________ 
Participant Name (print name) 
 
_____________________________________________ ________________________ 
Signature of Participant      Date 
 
_____________________________________________ ________________________ 
Signature of Witness       Date 
 
I, or one of my colleagues, have carefully explained to the subject, the nature of the above 
research study.  I certify that, to the best of my knowledge, the subject clearly understands the 
nature of the study and the demands, benefits and risks involved in participating in the study. 
 
_____________________________________________ 
Investigator (or Designee) Name (please print) 
 
_____________________________________________ ________________________ 
Investigator (or Designee) Signature     Date 
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APPENDIX 2 
PULMONARY REHABILITATION SCHEDULE 
 
Frequency:  3 days per week 
Duration of session: 1 hour 
 
Group warm up (20 minutes): 
 Low intensity aerobic warm up 
 Stretching 
 Balance exercises 
 Strengthening with resistance bands 
 
Individual aerobic activity (40 minutes): 
 Individuals may choose any combination of the following activities: 
Walking 
Jogging 
Lower extremity ergometry 
Upper extremity ergometry 
Rowing 
 Intensity: 5-6 on a 0-10 Borg rating of perceived exertion scale for shortness of breath 
 
Education sessions are offered occasionally during the year 
 
